SCHEMBL29960482

SCHEMBL29960482

C=Cc1ccccc1Oc1cccc(C(=O)OC)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.49
TP53 P04637 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
USP2 O75604 1/20 0.44
TSHR P16473 1/20 0.44
LMNA P02545 3/20 0.43
RAB9A P51151 5/20 0.43
MET P08581 1/20 0.42
ALK Q9UM73 1/20 0.42
NPC1 O15118 3/20 0.42
KMT2A Q03164 3/20 0.42
MAPT P10636 2/20 0.42
MEN1 O00255 2/20 0.42
HTT P42858 1/20 0.42
ALDH1A1 P00352 1/20 0.42
PKM P14618 1/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
AKR1C3 P42330 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20240298 0.88 LMNA (0.55) L3MBTL1TP53SMN1; SMN2USP2TSHR
SCHEMBL29960461 0.88 LMNA (0.55) L3MBTL1TP53SMN1; SMN2USP2TSHR
SCHEMBL29960804 0.85 AKR1C3 (0.61) LMNARAB9ANPC1KMT2AHTT
SCHEMBL29960046 0.83 LMNA (0.48) SMN1; SMN2LMNANPC1KMT2AHTT
SCHEMBL27489857 0.79 L3MBTL1 (0.59) L3MBTL1TP53SMN1; SMN2USP2TSHR
SCHEMBL3507291 0.79 USP2 (0.61) L3MBTL1TP53SMN1; SMN2USP2TSHR
SCHEMBL2436534 0.79 L3MBTL1 (0.65) L3MBTL1TP53SMN1; SMN2TSHRRAB9A
SCHEMBL29960686 0.78 HDAC8 (0.40) SMN1; SMN2LMNARAB9ANPC1KMT2A
SCHEMBL521860 0.78 AKR1C3 (0.68) L3MBTL1TP53SMN1; SMN2TSHRLMNA
SCHEMBL18610115 0.77 POLB (0.54) L3MBTL1TP53SMN1; SMN2USP2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 WO disclosed